Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Half of 2016 Biotech IPOs Positive At Mid-Year; 2015 Success Rate Sours

Jul 10 2016

• By Mandy Jackson

stock

Related Content

VC Roundup: Three New Funds Close As Small, Early Financings Bounce Back

Jun 03 2016

IPO Update: With No New Offerings, Kadmon Steals The Spotlight

Jun 16 2016

VC Roundup: Annexon, Mersana Benefit As Investors Favor Private Over Public Biotechs

Jun 25 2016

IPO Update: Three More Biotechs Squeeze Through The Window

May 21 2016

IPO Update: Haircuts Needed To Price Biotech Offerings

Jun 04 2016

VC Roundup: More Funds Raise Cash For Biotech; Morphic Closes $51.5m Series A

Jul 04 2016

Related Companies

Kadmon Holdings, Inc.

Syros Pharmaceuticals, Inc.

Selecta Biosciences, Inc.

Clearside Biomedical, Inc.

Moleculin Biotech, Inc.

Reata Pharmaceuticals, Inc.

Merus N.V.

PhaseRx, Inc.

Outlook Therapeutics, Inc.

Spring Bank Pharmaceuticals Inc.

Intellia Therapeutics, Inc.

Spyre Therapeutics, Inc.

Corvus Pharmaceuticals, Inc.

HUTCHMED (China) Limited

Syndax Pharmaceuticals, Inc.

Proteostasis Therapeutics, Inc.

AveXis, Inc.

Editas Medicine

BeOne Medicines Ltd.

Additional Topics

Business Strategies Companies Commercial StartUps and SMEs BioPharmaceutical

More from Strategy

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window